CN1523036A - Anti-coagulate protein and its coding gene and high effective expression method - Google Patents
Anti-coagulate protein and its coding gene and high effective expression method Download PDFInfo
- Publication number
- CN1523036A CN1523036A CNA031046614A CN03104661A CN1523036A CN 1523036 A CN1523036 A CN 1523036A CN A031046614 A CNA031046614 A CN A031046614A CN 03104661 A CN03104661 A CN 03104661A CN 1523036 A CN1523036 A CN 1523036A
- Authority
- CN
- China
- Prior art keywords
- protein
- anticoagulant protein
- glu
- asp
- cys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 20
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 14
- 239000002506 anticoagulant protein Substances 0.000 claims abstract description 31
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 9
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 230000023555 blood coagulation Effects 0.000 claims description 21
- 108091008146 restriction endonucleases Proteins 0.000 claims description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 241000235648 Pichia Species 0.000 claims description 9
- 108010036986 Ancylostoma caninum anti-coagulant protein C2 Proteins 0.000 claims description 8
- 239000013613 expression plasmid Substances 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 241000244206 Nematoda Species 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 5
- 235000015097 nutrients Nutrition 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 4
- 108700005078 Synthetic Genes Proteins 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 101710132637 Protein C2 Proteins 0.000 abstract description 7
- 101710195626 Transcriptional activator protein Proteins 0.000 abstract description 7
- 108090000190 Thrombin Proteins 0.000 abstract description 5
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 238000003776 cleavage reaction Methods 0.000 abstract 2
- 238000010276 construction Methods 0.000 abstract 2
- 230000007017 scission Effects 0.000 abstract 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 64
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 28
- 239000006228 supernatant Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 102220369447 c.1352G>A Human genes 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000002429 anti-coagulating effect Effects 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 238000011207 functional examination Methods 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 229960004072 thrombin Drugs 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 241001147672 Ancylostoma caninum Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 108010074864 Factor XI Proteins 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 229960004676 antithrombotic agent Drugs 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 102000004411 Antithrombin III Human genes 0.000 description 1
- 108090000935 Antithrombin III Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100030563 Coagulation factor XI Human genes 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 108010029144 Factor IIa Proteins 0.000 description 1
- 108010076282 Factor IX Proteins 0.000 description 1
- 108010023321 Factor VII Proteins 0.000 description 1
- 108010054265 Factor VIIa Proteins 0.000 description 1
- 108010014173 Factor X Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- VABCILAOYCMVPS-UHFFFAOYSA-N acenocoumarol Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=C([N+]([O-])=O)C=C1 VABCILAOYCMVPS-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960000182 blood factors Drugs 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- DOBMPNYZJYQDGZ-UHFFFAOYSA-N dicoumarol Chemical compound C1=CC=CC2=C1OC(=O)C(CC=1C(OC3=CC=CC=C3C=1O)=O)=C2O DOBMPNYZJYQDGZ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940012414 factor viia Drugs 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- -1 r-hirudin Chemical compound 0.000 description 1
- 102220023256 rs387907547 Human genes 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 108010080213 vascular factor Proteins 0.000 description 1
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031046614A CN100355783C (en) | 2003-02-20 | 2003-02-20 | Anti-coagulate protein and its coding gene and high effective expression method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031046614A CN100355783C (en) | 2003-02-20 | 2003-02-20 | Anti-coagulate protein and its coding gene and high effective expression method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1523036A true CN1523036A (en) | 2004-08-25 |
CN100355783C CN100355783C (en) | 2007-12-19 |
Family
ID=34282302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031046614A Expired - Fee Related CN100355783C (en) | 2003-02-20 | 2003-02-20 | Anti-coagulate protein and its coding gene and high effective expression method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100355783C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101041690B (en) * | 2006-03-22 | 2010-10-06 | 北京大学 | Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof |
CN102617722A (en) * | 2007-03-05 | 2012-08-01 | 广东医学院 | Ancylostoma caninum anticoagulant peptide, preparation and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0788546B9 (en) * | 1994-10-18 | 2007-06-13 | Dendreon Corporation | Nematode-extracted serine protease inhibitors and anticoagulant proteins |
CN1194009C (en) * | 2000-09-12 | 2005-03-23 | 南京大学 | Anticoagulant protein mediated by anticoagulant protein of human placenta |
-
2003
- 2003-02-20 CN CNB031046614A patent/CN100355783C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101041690B (en) * | 2006-03-22 | 2010-10-06 | 北京大学 | Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof |
CN102617722A (en) * | 2007-03-05 | 2012-08-01 | 广东医学院 | Ancylostoma caninum anticoagulant peptide, preparation and application thereof |
CN102617722B (en) * | 2007-03-05 | 2013-10-16 | 广东医学院 | Ancylostoma caninum anticoagulant peptide, preparation and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN100355783C (en) | 2007-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1132845C (en) | Improved method for obtaining isulin precursor having correctly-bonded cystine bond | |
CN1311075C (en) | System for expressing hyperthermostable protein | |
CN1110323A (en) | Novel polypeptides and DNAS encoding them | |
CN1146207A (en) | Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors | |
CN101045933A (en) | Cryophilous proteinase gene mcp01 and its prepn process | |
CN1228447C (en) | Recombinant expression vector expressing human pancreatic tissue kallikrein gene and prepn of human pancreatic tissue kallikrein | |
CN1111909A (en) | Novel polypeptide and DNA coding for the same | |
CN1791614A (en) | Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzyme | |
CN1757739A (en) | Method of expressing heparinase and its special expression carrier | |
CN1275163A (en) | Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner | |
CN101041828A (en) | Domestic silkworm gene and expression and application in eukaryotic cell | |
CN1523036A (en) | Anti-coagulate protein and its coding gene and high effective expression method | |
CN1244698C (en) | Expression of recombination SARS virus gene in pleiomorphic Hansen yeast and its use | |
CN1295334C (en) | Wheat antidisense related gene TaEDR1 and its application | |
CN1163604C (en) | Attenuated virus oka strain gene 62 and method for identifying virus strain for attenuated live vaccine by using same | |
CN1257269C (en) | Method for producing 7-amino cephalosporanic acid and its specific recombinase | |
CN1256431C (en) | Recombined human parathyroid hormone gene, its expression carrier and preparing method of recombined human parathyroid protein | |
CN1643150A (en) | Gene participating in the synthesis of brassinosteroid | |
CN1280415C (en) | Wheat disease-resistant gene Lr-L1 and its use | |
CN101041690A (en) | Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof | |
CN1273600C (en) | Coding sequence of Chinese yew tarad-ane C13-lateral chain-N-benzoyl transiting enzymic protein | |
CN1614019A (en) | Secretory expression for human insulin gene in methyl alcohol yeast | |
CN1274828C (en) | Mouse derived EPOR outer cell region and human NOK intracell region infused acceptor and coding gene and uses | |
CN1257271C (en) | Serine proteinase and coded sequence thereof | |
CN1798837A (en) | Thioredoxin modification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WEIHAI DEYI RUNBANG BIOTECH CO., LTD. Free format text: FORMER OWNER: LIU FENGMING Effective date: 20120705 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100044 BEIJINGYILIGAOKESHENGWUGONGCHENGJISHUYANJIU INSTITUTE, NO.20, CHEGONGZHUANG ROAD(WEST), HAIDIAN DISTRICT, BEIJING CITY TO: 264205 2, -, NO.57, TIANDONGJIAYUAN, WEIHAI CITY ECONOMIC AND TECHNOLOGICAL DEVELOPMENT Z, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120705 Address after: 264205 No. 57, Tian Dong homeland, Weihai economic and Technological Development Zone, Shandong, -2 Patentee after: Weihai Deyi Runbang Biotechnology Co. Ltd. Address before: 100044 Beijing city Haidian District Chegongzhuang West Road No. 20, Beijing Yili high tech biological engineering technology research institute Patentee before: Liu Fengming |
|
DD01 | Delivery of document by public notice |
Addressee: Weihai Deyi Runbang Biotechnology Co. Ltd. Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Weihai Deyi Runbang Biotechnology Co. Ltd. Document name: Notification to Pay the Fees |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071219 Termination date: 20160220 |